FRED HUTCHINSON CANCER CENTER
Iodine I 131 Monoclonal Antibody BC8, Fludarabine Phosphate, Cyclophosphamide, Total-Body Irradiation and Donor Bone Marrow Transplant in Treating Patients With Advanced Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or High-Risk Myelodysplastic Syndrome
- Conditions
- Acute Myeloid Leukemia Arising From Previous Myelodysplastic SyndromeAdult Acute Myeloid Leukemia in RemissionCD45-Positive Neoplastic Cells PresentRefractory Anemia With Ring SideroblastsChronic Myelomonocytic LeukemiaRefractory Anemia With Excess BlastsRefractory Cytopenia With Multilineage Dysplasia and Ring SideroblastsAdult Acute Lymphoblastic Leukemia in RemissionPreviously Treated Myelodysplastic SyndromeRefractory Cytopenia With Multilineage Dysplasia
- Interventions
- First Posted Date
- 2008-01-09
- Last Posted Date
- 2023-02-09
- Lead Sponsor
- Fred Hutchinson Cancer Center
- Target Recruit Count
- 26
- Registration Number
- NCT00589316
- Locations
- 🇺🇸
Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States
Alemtuzumab, Busulfan, and Cyclophosphamide Followed By a Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer
- Conditions
- Interventions
- First Posted Date
- 2007-11-07
- Last Posted Date
- 2017-05-24
- Lead Sponsor
- Fred Hutchinson Cancer Center
- Target Recruit Count
- 1
- Registration Number
- NCT00555048
- Locations
- 🇺🇸
Fred Hutchinson Cancer Research Center, Seattle, Washington, United States
🇺🇸Seattle Cancer Care Alliance, Seattle, Washington, United States
Laboratory-Treated T Cells and Aldesleukin After Cyclophosphamide in Treating Patients With Stage IV Melanoma
- First Posted Date
- 2007-11-04
- Last Posted Date
- 2017-02-15
- Lead Sponsor
- Fred Hutchinson Cancer Center
- Target Recruit Count
- 10
- Registration Number
- NCT00553306
- Locations
- 🇺🇸
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium, Seattle, Washington, United States
Alemtuzumab, Fludarabine Phosphate, and Total-Body Irradiation Followed by a Donor Stem Cell Transplant in Treating Patients With Immunodeficiency or Other Nonmalignant Inherited Disorders
- Conditions
- Interventions
- First Posted Date
- 2007-11-04
- Last Posted Date
- 2020-02-17
- Lead Sponsor
- Fred Hutchinson Cancer Center
- Target Recruit Count
- 29
- Registration Number
- NCT00553098
- Locations
- 🇺🇸
Children's Hospital and Research Center at Oakland, Oakland, California, United States
🇺🇸Oregon Health and Science University, Portland, Oregon, United States
🇺🇸Cleveland Clinic Foundation, Cleveland, Ohio, United States
Sonographic Visibility of Breast Biopsy Marker Clips Up to 4 Weeks After Placement
- Conditions
- First Posted Date
- 2007-10-24
- Last Posted Date
- 2008-12-31
- Lead Sponsor
- Fred Hutchinson Cancer Center
- Target Recruit Count
- 25
- Registration Number
- NCT00548392
- Locations
- 🇺🇸
Seattle Cancer Care Alliance, Seattle, Washington, United States
Emergency Use of Adoptive Immunotherapy With CMV-Specific T Cells After Donor Bone Marrow Transplant of an Infant With Immunodeficiency Syndrome and CMV Infection
- First Posted Date
- 2007-10-22
- Last Posted Date
- 2010-08-24
- Lead Sponsor
- Fred Hutchinson Cancer Center
- Registration Number
- NCT00547235
- Locations
- 🇺🇸
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium, Seattle, Washington, United States
Effects of Garlic Supplements on Opioids in Healthy Volunteers
- Conditions
- Interventions
- First Posted Date
- 2007-07-11
- Last Posted Date
- 2017-04-07
- Lead Sponsor
- Fred Hutchinson Cancer Center
- Target Recruit Count
- 15
- Registration Number
- NCT00499460
- Locations
- 🇺🇸
Fred Hutchinson Cancer Research Center, Seattle, Washington, United States
Beclomethasone Dipropionate in Preventing Acute Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer
- Conditions
- Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia With Inv(16)(p13;q22)Hematopoietic/Lymphoid CancerAdult Acute Myeloid Leukemia With t(15;17)(q22;q12)Childhood Acute Myeloid Leukemia in RemissionChronic Eosinophilic LeukemiaChronic Phase Chronic Myelogenous LeukemiaContiguous Stage II Adult Diffuse Small Cleaved Cell LymphomaContiguous Stage II Grade 3 Follicular Lymphoma
- Interventions
- First Posted Date
- 2007-06-21
- Last Posted Date
- 2021-02-03
- Lead Sponsor
- Fred Hutchinson Cancer Center
- Target Recruit Count
- 140
- Registration Number
- NCT00489203
- Locations
- 🇺🇸
Hackensack University Medical Center, Hackensack, New Jersey, United States
🇺🇸Fred Hutchinson Cancer Research Center, Seattle, Washington, United States
Yoga Study in Breast Cancer Patients
- Conditions
- Interventions
- First Posted Date
- 2007-05-21
- Last Posted Date
- 2012-11-28
- Lead Sponsor
- Fred Hutchinson Cancer Center
- Target Recruit Count
- 63
- Registration Number
- NCT00476203
- Locations
- 🇺🇸
Fred Hutchinson Cancer Research Center, Seattle, Washington, United States
Tositumomab and Iodine I 131 Tositumomab in Treating Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma in First Remission
- Conditions
- Interventions
- First Posted Date
- 2007-05-21
- Last Posted Date
- 2017-10-12
- Lead Sponsor
- Fred Hutchinson Cancer Center
- Target Recruit Count
- 16
- Registration Number
- NCT00476047
- Locations
- 🇺🇸
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium, Seattle, Washington, United States